Engineered Microparticles Reprogram Immune Cells to Fight Cancer More Effectively

Cancer cells are notorious for hijacking the immune system, particularly by converting helpful immune cells called macrophages into tumor-supporting accomplices. This study addresses a critical challenge in cancer treatment: how to reprogram these corrupted immune cells back into cancer fighters.

Researchers developed succinate-loaded microparticles (SMPs) derived from tumor cell membranes that can metabolically reprogram tumor-associated macrophages. When these engineered particles deliver succinate into macrophages, they trigger a dramatic shift from the tumor-promoting M2 phenotype to the cancer-fighting M1 phenotype.

The mechanism involves succinate entering both mitochondria and cell nuclei, where it modifies key proteins through succinylation. Specifically, it modifies isocitrate dehydrogenase 2 (IDH2) and histone H3K122, leading to enhanced glycolysis and reduced TCA cycle activity - metabolic changes that favor anti-tumor activity.

This approach is particularly promising because it uses endogenous metabolites rather than synthetic drugs, potentially reducing side effects. The microparticle delivery system could be broadly applicable for other posttranslational modification-based therapies. For longevity research, this work demonstrates how metabolic reprogramming can restore proper immune function, which naturally declines with age and contributes to cancer susceptibility in older adults.